Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
720.41
619.99
708.46
681.85
641.92
590.62
560.01
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
720.41
619.99
708.46
681.85
641.92
590.62
560.01
Raw Material Cost
227.72
192.69
188.08
189.26
214.39
161.31
148.38
Purchase of Finished goods
106.14
171.55
160.96
111.95
134.32
167.24
162.98
(Increase) / Decrease In Stocks
-25.27
-102.43
-23.82
-2.87
-90.31
-66.76
-41.53
Employee Cost
103.80
98.39
97.22
88.44
84.16
80.48
79.75
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
-0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
163.52
159.67
159.09
156.30
152.55
119.93
100.80
Total Expenditure (Excl Depreciation)
575.91
519.87
581.53
543.08
495.11
462.19
450.37
Operating Profit (PBDIT) excl Other Income
144.50
100.12
126.93
138.77
146.81
128.43
109.64
Other Income
21.57
5.64
15.34
27.85
-0.07
14.95
16.53
Operating Profit (PBDIT)
166.07
105.76
142.27
166.62
146.74
143.38
126.17
Interest
5.82
6.07
3.44
2.67
2.63
2.92
4.84
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
160.25
99.69
138.83
163.95
144.11
140.46
121.33
Depreciation
26.92
23.10
22.74
20.69
19.51
20.44
21.06
Profit Before Tax
133.33
76.60
116.09
143.26
124.60
120.02
100.28
Tax
34.20
18.40
25.37
38.19
26.84
30.95
22.63
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
99.14
58.20
90.73
105.07
97.76
89.07
77.64
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
99.14
58.20
90.73
105.07
97.76
89.07
77.64
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.89
-0.12
0.18
0.50
1.04
0.32
-0.65
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
98.25
58.32
90.55
104.56
96.72
88.75
78.29
Equity Capital
45.32
45.32
45.32
45.32
45.32
45.32
45.32
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
2,236.08
0.00
0.00
Earnings per share (EPS)
2.17
1.29
2.0
2.31
2.13
1.96
1.73
Diluted Earnings per share
2.17
1.29
2.0
2.31
2.13
1.96
1.73
Operating Profit Margin (Excl OI)
20.06%
16.15%
17.92%
20.35%
22.87%
21.74%
19.58%
Gross Profit Margin
22.24%
16.08%
19.6%
24.04%
22.45%
23.78%
21.67%
PAT Margin
13.76%
9.39%
12.81%
15.41%
15.23%
15.08%
13.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 16.20% vs -12.49% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 68.47% vs -35.59% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 44.33% vs -21.12% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -4.12% vs 76.45% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Marksans Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
720.41
0
720.41
Other Operating Income
0.00
0.00
0.00
Total Operating income
720.41
0
720.41
Raw Material Cost
227.72
0
227.72
Purchase of Finished goods
106.14
0
106.14
(Increase) / Decrease In Stocks
-25.27
0
-25.27
Employee Cost
103.80
0
103.80
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
163.52
0.00
163.52
Total Expenditure (Excl Depreciation)
575.91
0
575.91
Operating Profit (PBDIT) excl Other Income
144.50
0.00
144.50
Other Income
21.57
0
21.57
Operating Profit (PBDIT)
166.07
0
166.07
Interest
5.82
0
5.82
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
160.25
0
160.25
Depreciation
26.92
0
26.92
Profit Before Tax
133.33
0
133.33
Tax
34.20
0
34.20
Provisions and contingencies
0.00
0
0.00
Profit After Tax
99.14
0
99.14
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
99.14
0
99.14
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.89
0
0.89
Other related items
0.00
0.00
0.00
Consolidated Net Profit
98.25
0
98.25
Equity Capital
45.32
0
45.32
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
2.17
0
2.17
Diluted Earnings per share
2.17
0
2.17
Operating Profit Margin (Excl OI)
20.06%
0%
0.00
20.06%
Gross Profit Margin
22.24%
0%
0.00
22.24%
PAT Margin
13.76%
0%
0.00
13.76%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 720.41 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 16.20% vs -12.49% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 12.23% vs 20.83% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 98.25 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 68.47% vs -35.59% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 1.58% vs 15.80% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 144.50 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 44.33% vs -21.12% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -1.57% vs 28.84% in Sep 2024
Quarterly - Interest
Interest 5.82 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is -4.12% vs 76.45% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 121.29% vs 61.35% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.06%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
